The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Zeiher Bernhardt G since 2025.
This trader's CIK number is 1971421.
At the time of last reporting, Zeiher Bernhardt G was the Director of Entrada Therapeutics, Inc.. (stock ticker symbol TRDA).
Also see all insider trading activities at Entrada Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | TRDA | 5,000 | $29,315 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | AMLX | 10,000 | $37,010 | 0 | $0 | 0 | $0 |
1. Entrada Therapeutics, Inc. (TRDA)
2. Amylyx Pharmaceuticals, Inc. (AMLX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-05-20 | TRDA | Buy | 5,000 | 5.86 | 29,315 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-03-20 | AMLX | Buy | 10,000 | 3.70 | 37,010 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Zeiher Bernhardt G (Director of Entrada Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.